David Debruyne is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of DNA sequencing, holding three patents that enhance the accuracy and efficiency of massive parallel sequencing technologies.

Latest Patents

David's latest patents include "Methods and compositions for reducing base errors of massive parallel sequencing using triseq sequencing" and "Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules." The first patent, which may be referred to as Triseq sequencing, involves a two-part method. The first part includes ligating a UMI adapter, amplifying DNA fragments with dUTP, enriching target molecules through primer extension, and removing dU-containing template DNA. The second part focuses on sequencing the DNA library by NGS and deducing consensus sequences from subclones and primary clones. The second patent, known as SubDivision-Seq, also comprises two parts. The first part involves creating a target-enriched DNA library and organizing UMIs on DNA molecules. The second part includes sequencing the library by NGS and deducing consensus sequences.

Career Highlights

David Debruyne is currently employed at Paragon Genomics, Inc., where he continues to innovate in the field of genetic research. His work has significantly impacted the methodologies used in DNA sequencing, making it more reliable and efficient.

Collaborations

David collaborates with talented coworkers, including Zhitong Liu and Chenyu Li, who contribute to the advancements in their shared field of expertise.

Conclusion

David Debruyne's innovative work in DNA sequencing technologies exemplifies the importance of research and development in genetics. His patents reflect a commitment to improving the accuracy of sequencing methods, which is crucial for advancements in medical and scientific research.